Bengaluru, India

Pradeep Kumar

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Cytiva Sweden Ab, Doc Buddy Inc., Omnissa, LLC. Active years: 2026.

USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 1.8

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Pradeep Kumar - Innovator in Perfusion Systems

Introduction

Pradeep Kumar is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of bioprocessing, particularly in the operation of perfusion systems. His innovative approach has led to the development of a unique method that enhances the efficiency of fluid separation in bioreactors.

Latest Patents

Pradeep Kumar holds a patent for a method of operation of a perfusion system. This method involves inducing a first quantity of a feed fluid to flow from a bioreactor to a tangential flow filter. The process separates the feed fluid into a permeate fluid and a retentate fluid. The control unit is designed to manage the flow of the feed fluid and direct additional flows from the bioreactor, permeate fluid, and nutrient fluid in an efficient manner.

Career Highlights

Pradeep Kumar is currently employed at Cytiva Sweden AB, where he continues to work on innovative solutions in bioprocessing. His expertise in the field has allowed him to contribute to advancements that improve the performance of bioreactors and filtration systems.

Collaborations

Pradeep collaborates with talented coworkers, including Victor Jose and Prashanth Hosabettu Mohan. Their combined efforts in research and development have fostered a productive environment for innovation.

Conclusion

Pradeep Kumar's work in perfusion systems exemplifies the impact of innovative thinking in bioprocessing. His patent and contributions to Cytiva Sweden AB highlight his commitment to advancing technology in this critical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…